Revumenib was generally well-tolerated in combination with venetoclax/azacitidine in older, newly diagnosed mNPM1 and KMT2Ar AML patients – – Promising clinical activity and deep responses observed ...

Panelists emphasize that patients with KMT2A-rearranged acute myeloid leukemia (AML) often face steep educational challenges at diagnosis, requiring clear communication about the subtype’s ...

Three years ago, before I learned that I had metastatic cancer, doctors repeatedly told me I was “too young” to be seriously ...

Carmen Iris Albaladejo told Newsweek that her husband "feels the weight of his life being taken from him piece by piece" following his diagnosis.

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...